ZOMDF
Zomedica Corp.
$0.1000
+2.04%
No data for this timeframe.
Vol
Inst. Holders4 funds
Inst. Value$21.9K
Inst. Activity3 buys / 0 sells
SEC Reports2
Recent Activity
May 6, 2026
SEC
Zomedica reported record Q1 2026 revenue of $8.8M (+35% YoY), driven by diagnostics growth (+73%) and consumables (+22%)
8-K — Impact 6/10
Apr 24, 2026
SEC
Zomedica Corp. filed a DEFA14A, which is a definitive proxy statement related to a shareholder vote. The filing contains
DEFA14A — Impact 3/10
Inst.
UBS Group AG — DOUBLED
3,935,437 shares ($472.3K)
Inst.
WELLS FARGO & COMPANY/MN — DOUBLED
255,001 shares ($30.6K)
Analyst Ratings
3Strong Buy
5Buy
1Hold
0Sell
0Strong Sell
Latest Reports
BULLISH
8-K
6/10
Zomedica reported record Q1 2026 revenue of $8.8M (+35% YoY), driven by diagnostics growth (+73%) and consumables (+22%)
May 6, 2026
NEUTRAL
DEFA14A
3/10
Zomedica Corp. filed a DEFA14A, which is a definitive proxy statement related to a shareholder vote. The filing contains
Apr 24, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| Orion Porfolio Solutions, LLC | $20.7K | — |
| Cerity Partners LLC | $1.2K | — |
| TD Waterhouse Canada Inc. | $55.00 | TRIM |
| COMMONWEALTH EQUITY SERVICES, LLC | $10.00 | — |
4 institutional holders with $21.9K total value (558,961 shares) as of 2025-Q1. Top holders: Orion, Cerity, TD.
Top Institutional Holders — 2025-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | Orion Porfolio Solutions, LLC | 357,151 | $20.7K | 94.4% | — |
| 2 | Cerity Partners LLC | 20,000 | $1.2K | 5.3% | — |
| 3 | TD Waterhouse Canada Inc. | 925 | $55.00 | 0.3% | TRIM -69.2% |
| 4 | COMMONWEALTH EQUITY SERVICES, LLC | 180,885 | $10.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | DOUBLED | 44,528 | 3,935,437 | +8738.1% | $472.3K | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 105,001 | 255,001 | +142.9% | $30.6K | 2024-Q4 |
| GABELLI FUNDS LLC | DOUBLED | 100,000 | 225,000 | +125.0% | $27.0K | 2024-Q4 |
| ROYAL BANK OF CANADA | TRIM | 4,091 | 2,750 | -32.8% | — | 2024-Q3 |
| TD Waterhouse Canada Inc. | TRIM | 3,000 | 925 | -69.2% | $120.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 89% buy across 9 analysts — 3 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Aug 1, 2025 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Jul 1, 2025 | 3 | 5 | 1 | 0 | 0 | 89% | |
| Jun 1, 2025 | 3 | 5 | 1 | 0 | 0 | 89% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.